The live cell imaging market is a segment within the life sciences and medical imaging industry that focuses on technologies and equipment for real-time visualization and analysis of living cells and tissues. Live cell imaging techniques, such as confocal microscopy and fluorescence microscopy, allow researchers to observe dynamic cellular processes, interactions, and responses to stimuli. This market serves research institutions, pharmaceutical companies, and academic laboratories engaged in cell biology, cancer research, and drug discovery, among other fields.
According to the new market research report "Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2028"
The global live cell imaging market in terms of revenue was estimated to be worth $2.7 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 10.2% from 2023 to 2028.
Request Sample Pages: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163914483
Driver: Growing availability of funds for research
The growing availability of funds for research will drive R&D in the pharmaceutical and biotechnology industries. The governments and various treatment centers of several countries are also promoting and supporting cell-based research. A large portion of government funding is provided to academic research societies (such as Maryland Stem Cell Research Commission, International Human Frontier Science Program Organization (HFSPO), National Institutes of Health (NIH), etc.) to promote cell-based research to advance the diagnostic and therapeutic applications of various types of cells in managing chronic and infectious diseases. Moreover, the growing government funding in regenerative medicine research is expected to drive the demand for advanced live cell imaging technologies, including high-resolution microscopy, image analysis software, and data management tools.
Key players in the live cell imaging market include Danaher (US), ZEISS Group (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (South Korea), GE Healthcare (US), Bruker Corporation (US), Becton, Dickinson and Company (BD) (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Blue-Ray Biotech Corp. (Taiwan), CYTENA GmbH (Germany), Nanolive SA (Switzerland), Abberior (Germany), Phase Holographic Imaging (PHI) AB (Sweden), Cytoskeleton, Inc. (US), Corning Incorporated (US), KEYENCE Corporation (Japan), and Aligned Genetics, Inc. (South Korea).
Report Objectives
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure and profile the key players of the market and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.marketsandmarkets.com/Market-Reports/live-cell-imaging-market-163914483.html
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies -helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, and facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn, and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1–888–600–6441
Email: [email protected]
